Sarcoma: ASCO Tumor Boards

Product ID : TSA17
Price: $15.00
You will receive a link to your product from within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend



This is a case-based activity that includes discussion of a 65-year-old man that was asymptomatic; however, following a car accident he had temporary back pain. Biopsy of the mass and lung nodules revealed a high grade, metastatic leiomyosarcoma.


At the end of this course, users should be able to:

•             Describe emerging evidence for olaratumab in combination with doxorubicin for the treatment of soft tissue sarcoma (STS)

•             Explain the FDA's rationale for approval of eribulin in liposarcoma, but not leiomyosarcoma (LMS)

•             Determine potential treatment options for a patient with metastatic LMS


IMPORTANT NOTE: This course expires on July 19, 2020. Participants must complete all necessary course components by this date.


Purchase the 2017 ASCO Tumor Boards Bundle to access to all 2017 ASCO Tumor Boards for added savings. Purchased separately, these items would be $180 altogether. When bundled, you save $55.